NCT01349114View on ClinicalTrials.gov

Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects

PHASE4TerminatedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
DiabetesPre-hypertensionHypertension
Interventions
DRUG

aliskiren 300 mg once daily

aliskiren 300 mg daily

DRUG

Placebo/sugar pill

Sugar pill/placebo

Trial Locations (1)

35294

UAB, Birmingham

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University of Alabama at Birmingham

OTHER